Background
Rheumatoid arthritis (RA) is a chronic autoimmune disease of the joints, with frequent extra-articular complications including cardiovascular disease and cardiac fibrosis from multiple causes. Diffuse myocardial fibrosis can be detected non-invasively by extracellular volume (ECV) mapping based on pre-and postcontrast T1 measurements using cardiovascular magnetic resonance (CMR). We therefore hypothesized that CMR T1 mapping can detect subclinical diffuse myocardial fibrosis in patients with RA.
Methods 39 RA patients (28 female, mean age 50 ± 12 years) and 39 matched controls (28 female, mean age 49 ± 12 years) without previously known cardiovascular disease underwent CMR at 1.5T. CMR assessments included late gadolinium enhancement (LGE) [IV gadoterate meglumine at 0.15 mmol/kg], T1 mapping, cine, tagging, and T2-weighted imaging.
Results
Focal fibrosis on LGE was found in 18 (46%) RA patients compared to none of controls. Two of these patients had evidence of subendocardial enhancement, in keeping with previously unknown myocardial infarction. Evidence of diffuse myocardial fibrosis in RA was supported by higher precontrast T1 values (973 ± 27 vs. 961 ± 18 ms, p = 0.03), lower postcontrast T1 values (450 ± 40 vs. 468 ± 32 ms, p = 0.04) and expansion of ECV (30.3 ± 3.4 vs. 27.9 ± 2.0 %, p < 0.001) -the 2 RA patients with MI were excluded from this analysis. Indices of diffuse myocardial fibrosis were significantly elevated in RA, regardless of the presence of LGE. There was no difference in left ventricular volumes, mass and ejection fraction between RA patients and controls. However, there were differences in regional function: peak systolic circumferential strain (-16.9 ± 1.3 vs. -18.7 ± 1.2, p < 0.001) and peak diastolic strain rate (83 ± 21 vs. 112 ± 20 s-1, p < 0.001) were impaired in RA patients. Indices of diffuse myocardial fibrosis correlated with impaired myocardial systolic strain, diastolic strain rate and RA disease activity. There was no evidence of myocardial edema in RA.
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